BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26614368)

  • 1. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
    Farley HA; Pommier RF
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Neuroendocrine Liver Metastases.
    Farley HA; Pommier RF
    Surg Oncol Clin N Am; 2016 Jan; 25(1):217-25. PubMed ID: 26610783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    J Am Coll Surg; 2010 Nov; 211(5):620-7. PubMed ID: 21035044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?
    Maxwell JE; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR
    Surgery; 2016 Jan; 159(1):320-33. PubMed ID: 26454679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
    Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
    Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
    Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
    World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications and operative procedures for neuroendocrine liver metastases].
    Musholt TJ; Lang H
    Chirurg; 2009 Feb; 80(2):113-21. PubMed ID: 19212693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
    Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
    Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
    Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
    J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. It May Not Be Too Little or Too Late: Resecting Primary Small Bowel Neuroendocrine Tumors in the Presence of Metastatic Disease.
    Howe JR
    Ann Surg Oncol; 2020 Aug; 27(8):2583-2585. PubMed ID: 32500346
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
    Gangi A; Anaya DA
    Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
    Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
    Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours.
    Norlén O; Stålberg P; Zedenius J; Hellman P
    Br J Surg; 2013 Oct; 100(11):1505-14. PubMed ID: 24037573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
    Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
    Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
    Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
    World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
    Hallet J; Law C;
    World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Lymphatic Metastasis of Small Bowel Neuroendocrine Tumors.
    Chen L; Chen M; Chen J
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):555-556. PubMed ID: 30600406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.